NEW YORK, Aug. 29 – Pyrosequencing and the University of Geneva have partnered to develop a diagnostic test for Down Syndrome, the company announced on Wednesday.

The molecular diagnostics business unit of Pyrosequencing will sponsor the university's research to analyze genes and develop a test based on the company's technology. Pyrosequencing said it had secured exclusive access to the intellectual property underlying the University of Geneva’s method to detect the gene.

Financial details of the agreement were not disclosed.